Ciaruffoli Robert J. 4

What Happened
Robert J. Ciaruffoli, a director of Medicus Pharma Ltd. (MDCX), was granted a derivative award for 50,000 shares on June 3, 2026. The Form 4 records the acquisition as an award/grant (code A) at $0.00 per share (reported consideration $0). This was a compensation-style option/award, not an open‑market purchase or sale.

Key Details

• Transaction date: June 3, 2026; Form 4 filed June 4, 2026 (appears timely).
• Transaction type/code: Award/Grant (A); reported price/consideration: $0.00 per share.
• Shares/units granted: 50,000 (derivative award).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: F1 — the option was granted June 3, 2026 and is scheduled to vest quarterly in four equal installments over one year.
• No indication in this filing that shares were exercised or sold immediately.

Context
This filing documents a stock‑based compensation grant (an option/award) to a director. Such grants are common as part of director compensation and do not necessarily indicate immediate buying or selling of stock. The award vests over time (quarterly over one year), meaning the director must remain in service to realize the full grant; exercise price and plan details were not provided in the excerpt.